G6PD ACTIVATOR AG1 - AN OVERVIEW

BACKGROUNDTriple-detrimental breast cancer (TNBC) is extremely intense with an increased metastatic incidence as compared to other breast cancer subtypes. Having said that, mainly because of the absence of clinically reputable biomarkers and targeted therapy in TNBC, outcomes are suboptimal. As a result, There exists an urgent need to be aware of b